Simulation Suite Upgrades Phase II Complete with the Installation of MRI
The commissioning of a newly installed Philips Ingenia 1.5T MRI scanner is complete and caps Phase II of renovation and upgrade to the simulation suite technology.
The simulation suite is where patients receive MRIs and CT scans used to develop treatment plans. The state-of-the-art medical imaging devices and software capture and process high-quality images rapidly, which means patients spend less time in a stationary position during the scan. This is especially helpful for pediatric patients who will no longer need to stay still as long or stay anesthetized as long.
“This advanced imaging technology represents a major leap forward in our treatment planning capabilities and patient care,” said Bradlee Robbert, FACHE, MHA, RT (R)(T), director of operations. “The Philips Ingenia 1.5T MRI scanner brings precision and efficiency to our diagnostic processes. The MRI can gather comprehensive imaging for treatment planning for specific conditions, sometimes making CT simulations unnecessary. This allows us to streamline the planning process, saving patients valuable time and enhancing our treatment process.”
Beyond its clinical benefits, the MRI is designed with sustainability in mind. Unlike traditional MRI machines, which typically consume around 2,000 liters of helium, this model uses only 5 liters—a tremendous reduction in resource use and cost. Given the current cost of helium at $35 per liter, this efficiency delivers significant financial savings while supporting our commitment to eco-friendly operations.
Robbert said, “We’re excited to see how this new MRI will support our mission to provide the highest-quality care. We’re grateful for our team's dedication to preparing for its integration. Thank you all for your continued support as we move forward with this exciting enhancement to our facility.”
Philanthropic gifts were instrumental in making the renovation and upgrades possible. The James M. Doss Foundation initiated a $150,000 Challenge Grant in November 2021, and it superseded the fundraising goal for Phase I of the project within four months. For Phase II of the project, the James M. Doss Foundation initiated a $50,000 Challenge Grant in December 2023, a goal that was met by March 2024.
“The generosity of the James M. Doss Foundation and donors who stepped forward to meet our fundraising goals is truly a gift for patients today and tomorrow. We are deeply grateful for their support,” said Kristin Heath, DBA, MBA, MHA, executive director.